CD8A and neoplasm: As a result, the Aposome group treated with a PD-L1 antibody showed improved tumor growth suppression with an 80% clearance rate (Figure 1E), and the upregulation of cytotoxic CD8+ T cells was observed from excreted tumor tissues in Aposome groups treated with PD-L1 antibody (Figure 1F).